Annual Drug Patent Expirations for DORIBAX
Doribax is a drug marketed by Shionogi Inc and is included in one NDA. There is one patent protecting this drug and one Paragraph IV challenge.
Drug patent litigation for DORIBAX.
This drug has eighteen patent family members in fifteen countries.
The generic ingredient in DORIBAX is doripenem. Additional details are available on the doripenem profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
